Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Allison

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
The Journal of Pediatrics|April 20, 2010
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006Oren Abramson, Michael Durant, William Mow, et al.
European Radiology|July 4, 2012
A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosisEdmund M Godfrey, Andrew J Patterson, Andrew N Priest, et al.
Mabs|September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in ratsLeslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 17, 2004
Craniopagus: the Suriname-Amsterdam conjunctionW J R van Ouwerkerk, R van den Berg, C E Allison, et al.
Annals of Internal Medicine|October 8, 2008
Stool DNA and occult blood testing for screen detection of colorectal neoplasiaDavid A Ahlquist, Daniel J Sargent, Charles L Loprinzi, et al.
The New England Journal of Medicine|October 2, 2004
Pure red-cell aplasia and epoetin therapyCharles L Bennett, Stefano Luminari, Allen R Nissenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation statusMichael S Gordon, Daniela Matei, Carol Aghajanian, et al.
The American Journal of Gastroenterology|October 11, 2017
Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study DesignJason A Dominitz, Douglas J Robertson, Dennis J Ahnen, et al.
Microbiology Resource Announcements|July 1, 2021
Complete Genome Sequence of the Cluster B4 Mycobacteriophage Lolalove, Isolated in Charleston, South CarolinaChristine A Byrum, Hannah Marie Rozier, Toni E Allison, et al.
JAMA|May 5, 2005
The Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Jonathan R Nebeker, E Allison Lyons, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
The Journal of Pediatrics|April 20, 2010
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006Oren Abramson, Michael Durant, William Mow, et al.
European Radiology|July 4, 2012
A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosisEdmund M Godfrey, Andrew J Patterson, Andrew N Priest, et al.
Mabs|September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in ratsLeslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|August 17, 2004
Craniopagus: the Suriname-Amsterdam conjunctionW J R van Ouwerkerk, R van den Berg, C E Allison, et al.
Annals of Internal Medicine|October 8, 2008
Stool DNA and occult blood testing for screen detection of colorectal neoplasiaDavid A Ahlquist, Daniel J Sargent, Charles L Loprinzi, et al.
The New England Journal of Medicine|October 2, 2004
Pure red-cell aplasia and epoetin therapyCharles L Bennett, Stefano Luminari, Allen R Nissenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation statusMichael S Gordon, Daniela Matei, Carol Aghajanian, et al.
The American Journal of Gastroenterology|October 11, 2017
Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study DesignJason A Dominitz, Douglas J Robertson, Dennis J Ahnen, et al.
Microbiology Resource Announcements|July 1, 2021
Complete Genome Sequence of the Cluster B4 Mycobacteriophage Lolalove, Isolated in Charleston, South CarolinaChristine A Byrum, Hannah Marie Rozier, Toni E Allison, et al.
JAMA|May 5, 2005
The Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Jonathan R Nebeker, E Allison Lyons, et al.
Pageof 28